ARK Investment Management - Q1 2019 holdings

$3.5 Billion is the total value of ARK Investment Management's 199 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 17.3% .

 Value Shares↓ Weighting
NVDA BuyNVIDIA Corp$231,466,000
+89.7%
1,289,075
+41.0%
6.61%
+33.5%
TSLA BuyTesla Inc$210,972,000
+53.1%
753,850
+82.0%
6.03%
+7.7%
SSYS BuyStratasys Ltd$172,931,000
+41.7%
7,259,928
+7.2%
4.94%
-0.3%
BIDU BuyBaidu Incadr$159,226,000
+37.6%
965,887
+32.4%
4.55%
-3.2%
TWTR BuyTwitter Inc$153,259,000
+65.4%
4,661,175
+44.6%
4.38%
+16.4%
ILMN BuyIllumina Inc$145,078,000
+52.8%
466,953
+47.5%
4.14%
+7.5%
NTLA BuyIntellia Therapeutics Inc$136,319,000
+46.8%
7,981,198
+17.3%
3.90%
+3.3%
EDIT BuyEditas Medicine Inc$111,478,000
+62.0%
4,559,434
+50.8%
3.18%
+14.0%
NSTG BuyNanoString Technologies Inc$83,193,000
+73.2%
3,476,526
+7.3%
2.38%
+21.9%
MDSO BuyMedidata Solutions Inc$81,871,000
+29.7%
1,117,845
+19.4%
2.34%
-8.8%
CRSP BuyCRISPR Therapeutics AG$72,262,000
+90.9%
2,023,017
+52.7%
2.06%
+34.4%
Z BuyZillow Group Inc$69,053,000
+20.1%
1,987,696
+9.1%
1.97%
-15.5%
LC BuyLendingClub Corp$66,290,000
+43.8%
21,453,157
+22.4%
1.89%
+1.2%
SPOT BuySpotify Technology SA$63,290,000
+40.9%
455,979
+15.2%
1.81%
-0.9%
CERS BuyCerus Corp$47,594,000
+39.3%
7,639,433
+13.3%
1.36%
-2.0%
MTLS BuyMaterialise NVadr$43,272,000
-12.2%
2,749,159
+11.7%
1.24%
-38.2%
AAPL BuyApple Inc$42,195,000
+152.2%
222,136
+109.5%
1.21%
+77.6%
TDOC BuyTeladoc Health Inc$40,959,000
+25.5%
736,673
+11.9%
1.17%
-11.7%
MCRB BuySeres Therapeutics Inc$36,327,000
+95.1%
5,287,713
+28.4%
1.04%
+37.3%
CGEN BuyCompugen Ltd$34,070,000
+120.9%
8,229,555
+15.8%
0.97%
+55.4%
PRLB BuyProto Labs Inc$30,619,000
+248.2%
291,222
+273.5%
0.88%
+145.1%
SYRS BuySyros Pharmaceuticals Inc$27,353,000
+99.6%
2,992,700
+21.6%
0.78%
+40.2%
BABA BuyAlibaba Group Holding Ltdadr$23,862,000
+80.2%
130,787
+35.4%
0.68%
+26.8%
ONVO BuyOrganovo Holdings Inc$19,839,000
+14.8%
19,998,670
+10.7%
0.57%
-19.2%
BuyGrayscale Bitcoin Trust BTCopen-end fund$18,687,000
+29.5%
3,909,488
+7.4%
0.53%
-8.9%
XONE BuyExOne Co/The$18,433,000
+40.7%
2,171,191
+9.7%
0.53%
-0.9%
PYPL BuyPayPal Holdings Inc$17,327,000
+66.7%
166,862
+35.0%
0.50%
+17.3%
CLLS BuyCellectis SAadr$17,131,000
+44.0%
934,076
+30.8%
0.49%
+1.2%
CLDR NewCloudera Inc$16,550,0001,512,759
+100.0%
0.47%
EB BuyEventbrite Inc$14,032,000
+230.7%
731,953
+379.7%
0.40%
+133.1%
GRUB BuyGrubHub Inc$11,651,000
+34.3%
167,706
+48.4%
0.33%
-5.4%
INO BuyInovio Pharmaceuticals Inc$10,927,000
+44.9%
2,929,597
+55.4%
0.31%
+2.0%
PDD BuyPinduoduo Incadr$10,162,000
+106.1%
409,739
+86.5%
0.29%
+45.0%
RUBY BuyRubius Therapeutics Inc$9,586,000
+89.1%
529,615
+68.1%
0.27%
+33.0%
BMY NewBristol-Myers Squibb Co$9,271,000194,317
+100.0%
0.26%
ADBE BuyAdobe Inc$8,311,000
+26.9%
31,188
+7.7%
0.24%
-10.9%
AVAV BuyAerovironment Inc$8,305,000
+5.7%
121,405
+5.0%
0.24%
-25.7%
ZUO BuyZuora Inc$7,578,000
+34.9%
378,316
+22.2%
0.22%
-4.8%
NTNX NewNutanix Inc$7,096,000188,019
+100.0%
0.20%
CDXS BuyCodexis Inc$6,392,000
+78.6%
311,368
+45.3%
0.18%
+26.2%
ARCT BuyArcturus Therapeutics Ltd$6,332,000
+71.5%
927,144
+13.7%
0.18%
+20.7%
TWLO BuyTwilio Inc$6,092,000
+50.8%
47,157
+4.2%
0.17%
+6.1%
ALGN BuyAlign Technology Inc$5,804,000
+46.5%
20,414
+7.9%
0.17%
+3.1%
INCY BuyIncyte Corp$5,789,000
+37.6%
67,305
+1.8%
0.16%
-3.5%
CBMG NewCellular Biomedicine Group Inc$4,944,000285,762
+100.0%
0.14%
BLCM BuyBellicum Pharmaceuticals Inc$4,649,000
+54.0%
1,379,629
+33.5%
0.13%
+8.1%
PSTI BuyPluristem Therapeutics Inc$3,679,000
+37.8%
3,793,249
+12.0%
0.10%
-2.8%
DDD Buy3D Systems Corp$1,919,000
+37.0%
178,320
+29.5%
0.06%
-3.5%
BuySLM Solutions Group AG$1,926,000
+48.4%
176,946
+40.3%
0.06%
+3.8%
GWRE BuyGuidewire Software Inc$1,705,000
+441.3%
17,546
+347.4%
0.05%
+276.9%
BuySBI Holdings Inc/Japan$1,659,000
+435.2%
74,400
+362.1%
0.05%
+261.5%
BuyRakuten Inc$1,641,000
+894.5%
173,000
+603.3%
0.05%
+571.4%
INTU BuyIntuit Inc$1,606,000
+524.9%
6,143
+370.0%
0.05%
+360.0%
NewZhongAn Online P&C Insurance C$1,390,000386,900
+100.0%
0.04%
VRSK BuyVerisk Analytics Inc$1,354,000
+521.1%
10,180
+408.2%
0.04%
+333.3%
NewLINE Corp$1,364,00038,687
+100.0%
0.04%
NewMeituan Dianping$1,143,000169,600
+100.0%
0.03%
NewAdyen NV$1,079,0001,378
+100.0%
0.03%
NewIntercure Ltd$1,052,000323,056
+100.0%
0.03%
IBKR BuyInteractive Brokers Group Inc$1,017,000
+298.8%
19,604
+319.4%
0.03%
+190.0%
ICE BuyIntercontinental Exchange Inc$993,000
+487.6%
13,041
+480.1%
0.03%
+300.0%
NewWirecard AG$880,0007,019
+100.0%
0.02%
TRU BuyTransUnion$843,000
+614.4%
12,617
+506.0%
0.02%
+380.0%
HDB BuyHDFC Bank Ltdadr$771,000
+475.4%
6,650
+412.7%
0.02%
+340.0%
BuyFirstRand Ltd - F Share$722,000
+324.7%
161,415
+361.4%
0.02%
+200.0%
AQB BuyAquaBounty Technologies Inc$735,000
+21.5%
335,420
+13.7%
0.02%
-16.0%
NDAQ BuyNasdaq Inc$724,000
+297.8%
8,274
+270.7%
0.02%
+200.0%
SCHW BuyCharles Schwab Corp/The$736,000
+374.8%
17,212
+360.5%
0.02%
+250.0%
NNDM BuyNano Dimension Ltdadr$571,000
+0.2%
804,275
+56.8%
0.02%
-30.4%
RDHL BuyRedhill Biopharma Ltdadr$548,000
+62.6%
65,918
+8.5%
0.02%
+14.3%
BuyArrk Corp$557,000
+60.5%
581,601
+15.2%
0.02%
+14.3%
SILC BuySilicom Ltd$519,000
+21.0%
13,572
+10.6%
0.02%
-11.8%
TSEM BuyTower Semiconductor Ltd$524,000
+42.8%
31,661
+27.3%
0.02%0.0%
NUVA BuyNuVasive Inc$510,000
+54.1%
8,984
+34.4%
0.02%
+15.4%
EVGN BuyEvogene Ltd$525,000
+5.2%
286,748
+13.7%
0.02%
-25.0%
NewFMS Enterprises Migun Ltd$483,00017,503
+100.0%
0.01%
NewBrainsway Ltd$485,00078,847
+100.0%
0.01%
KMDA BuyKamada Ltd$484,000
+13.9%
86,028
+0.9%
0.01%
-17.6%
GLMD BuyGalmed Pharmaceuticals Ltd$439,000
+57.3%
53,749
+31.6%
0.01%
+18.2%
FARO BuyFARO Technologies Inc$454,000
+11.8%
10,334
+3.5%
0.01%
-18.8%
GE BuyGeneral Electric Co$460,000
+61.4%
46,058
+22.5%
0.01%
+8.3%
UCTT BuyUltra Clean Holdings Inc$467,000
+39.8%
45,165
+14.6%
0.01%
-7.1%
UPS BuyUnited Parcel Service Inc$472,000
+19.8%
4,222
+4.6%
0.01%
-18.8%
SEDG BuySolarEdge Technologies Inc$459,000
+9.3%
12,175
+1.6%
0.01%
-23.5%
FOMX BuyFoamix Pharmaceuticals Ltd$440,000
+29.8%
117,367
+24.4%
0.01%
-7.1%
RDCM BuyRADCOM Ltd$427,000
+9.5%
57,532
+9.4%
0.01%
-25.0%
TEVA BuyTeva Pharmaceutical Industriesadr$384,000
+5.5%
24,462
+3.6%
0.01%
-26.7%
BuyBezeq The Israeli Telecommunic$352,000
-19.6%
503,335
+12.1%
0.01%
-44.4%
CELJF BuyCellcom Israel Ltd$308,000
-34.3%
84,977
+6.9%
0.01%
-52.6%
LN BuyLINE Corp - ADRadr$252,000
+86.7%
7,166
+80.8%
0.01%
+40.0%
KLAC NewKLA-Tencor Corp$256,0002,144
+100.0%
0.01%
BuyWirecard AG - ADRadr$203,000
+26.1%
3,242
+55.1%
0.01%
-14.3%
WAB NewWabtec Corp$18,000246
+100.0%
0.00%
BuyArkema SA$48,000
+11.6%
500
+0.2%
0.00%
-50.0%
CRS BuyCarpenter Technology Corp$51,000
+34.2%
1,108
+3.4%
0.00%
-50.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-13
Signatures

The EDGAR filing(s) were signed by:

About ARK Investment Management

ARK Investment Management is a New York-based investment management firm that specializes in actively managed exchange-traded funds (ETFs). The company was founded in 2014 by Catherine Wood, who serves as the CEO and Chief Investment Officer. ARK's investment philosophy is centered around disruptive innovation, which involves investing in companies that are at the forefront of technological advancements and are poised to disrupt traditional industries.

ARK's ETFs cover a range of themes, including genomics, robotics, fintech, and next-generation internet. The company's flagship fund, the ARK Innovation ETF (ARKK), has been one of the best-performing ETFs in recent years, with a 5-year annualized return of over 35%. Other popular ARK ETFs include the ARK Genomic Revolution ETF (ARKG) and the ARK Next Generation Internet ETF (ARKW).

In addition to Catherine Wood, ARK's leadership team includes COO Jane Kanter, CFO/CIO/CLO Brett Winton, and Director of Research Sam Korus. The company has gained a reputation for its innovative investment strategies and its willingness to take bold positions in emerging technologies. However, as with any investment, there are risks involved, and investors should carefully consider their investment objectives and risk tolerance before investing in ARK's ETFs.

Overall, ARK Investment Management has established itself as a leading player in the ETF industry, and its focus on disruptive innovation has resonated with investors looking for exposure to high-growth companies.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TESLA MTRS INC27Q3 20238.7%
SQUARE INC - A27Q3 20236.8%
STRATASYS LTD27Q3 20238.0%
INVITAE CORP27Q3 20237.8%
INTELLIA THERAPEUTICS INC27Q3 20235.0%
NVIDIA CORP27Q3 20236.6%
AMAZON.COM INC27Q3 20235.6%
2U INC27Q3 20233.9%
VERACYTE INC27Q3 20232.5%
PROTO LABS INC27Q3 20233.3%

View ARK Investment Management's complete holdings history.

Latest significant ownerships (13-D/G)
ARK Investment Management Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Ark Venture FundMarch 22, 202355,45539.4%
CODEXIS, INC.February 10, 20233,941,9856.0%
Coinbase Global, Inc.February 10, 20239,189,2735.1%
DraftKings Inc.February 10, 202325,032,0845.6%
EXACT SCIENCES CORPFebruary 10, 202316,040,4909.0%
KRATOS DEFENSE & SECURITY SOLUTIONS, INC.February 10, 20237,748,3576.2%
MATERIALISE NVFebruary 10, 20233,592,9796.6%
Schrodinger, Inc.February 10, 20233,852,0376.2%
Surface Oncology, Inc.February 10, 20235,567,2249.2%
Dynamics Special Purpose Corp.February 10, 20222,371,89110.0%

View ARK Investment Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-11
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-01-29
SC 13G/A2024-01-29
SC 13G/A2024-01-29
SC 13G/A2024-01-29
SC 13G/A2024-01-29
SC 13G/A2024-01-29
SC 13G/A2024-01-29

View ARK Investment Management's complete filings history.

Compare quarters

Export ARK Investment Management's holdings